文献速递头颈外科

淋巴血管间隙浸润与淋巴结阴性口腔舌癌局部区域失败及生存的关联

Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2017-01-01

回顾性分析2003至2013年接受根治性手术的180例淋巴结阴性口腔舌癌患者,中位随访4.9年。多因素分析显示淋巴血管间隙浸润(LVSI)与更差的局部区域控制(OR 0.06)和总生存(HR 2.20)相关,LVSI患者3年局部区域控制率38.8%低于无LVSI者的81.9%。

要点

  • 淋巴结阴性口腔舌癌中LVSI阳性者3年局部区域控制率38.8%,低于LVSI阴性者的81.9%。
  • LVSI阳性者3年总生存率71.3%,低于LVSI阴性者的90.3%。
  • 多因素分析中LVSI与更差局部区域控制(OR 0.06)和总生存(HR 2.20)相关。

核心结论

  • 在淋巴结阴性口腔舌癌接受 upfront 根治性手术的患者中,LVSI与更差的局部区域控制和总生存相关。
  • 作者认为伴LVSI的淋巴结阴性口腔癌值得考虑进一步辅助治疗,并应在前瞻性环境中进一步评估。

研究设计与样本

  • 回顾性病历审查,纳入2003至2013年接受根治性手术的口腔舌癌患者。
  • 所有患者临床淋巴结阴性(cN0),行颈淋巴结清扫者经病理确认为淋巴结阴性(pN0)。
  • 共180例符合入组标准,中位随访4.9年(范围0.9-12.5年)。
  • 采用Kaplan-Meier、多因素logistic回归和Cox比例风险回归分析。

主要发现

  • 180例中女性102例(56.7%),诊断时年龄小于45岁者42例(23.3%)。
  • 153例(85%)为T1/T2肿瘤,112例(62%)行选择性颈淋巴结清扫并确认pN0;LVSI见于36例(20%)。
  • 多因素分析:LVSI与更差局部区域控制相关(OR 0.06;95%CI 0.02-0.19;P<.01),选择性颈淋巴结清扫(OR 2.99;95%CI 1.16-7.73;P=.02)和接受放疗(OR 7.74;95%CI 2.27-26.42;P<.01)与改善的局部区域控制相关。
  • LVSI患者3年局部区域控制率38.8%(95%CI 22.8%-54.6%),低于无LVSI者的81.9%(95%CI 74.4%-87.4%)。
  • 多因素分析中仅LVSI(HR 2.20;95%CI 1.19-4.06;P=.01)和年龄大于44岁(HR 4.38;95%CI 1.34-14.27;P=.01)与更差总生存相关;LVSI患者3年总生存率71.3%(95%CI 53.2%-83.4%),低于无LVSI者的90.3%(95%CI 83.8%-94.3%)。

关键数值与推荐

  • LVSI阳性患者3年局部区域控制率38.8%(95%CI 22.8%-54.6%),LVSI阴性患者81.9%(95%CI 74.4%-87.4%)。
  • LVSI阳性患者3年总生存率71.3%(95%CI 53.2%-83.4%),LVSI阴性患者90.3%(95%CI 83.8%-94.3%)。
  • 多因素分析中LVSI与局部区域控制相关OR 0.06(95%CI 0.02-0.19;P<.01),与总生存相关HR 2.20(95%CI 1.19-4.06;P=.01)。

临床怎么用

  • 作者认为伴LVSI的淋巴结阴性口腔癌值得考虑进一步辅助治疗,该问题应在前瞻性环境中进一步评估。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The indications for adjuvant therapy in resected oral tongue cancers are based on both clinical and pathological factors, with clear evidence for adjuvant radiation in patients with pathologically positive neck lymph nodes, positive margins, and extracapsular extension, but the data for patients with no nodal disease are sparse. OBJECTIVE: To investigate determinants of failure and survival in patients with node-negative oral tongue cancer. DESIGN, SETTING, AND PARTICIPANTS: Medical records for patients with oral tongue cancer treated with definitive surgery from 2003 to 2013 were reviewed. All patients were cN0 negative and classified as pathologically node-negative (pN0) if a neck dissection was performed. Patients received adjuvant radiotherapy (RT) or chemoradiotherapy (CRT) based on standard clinical and pathological determinants. MAIN OUTCOMES AND MEASURES: Kaplan-Meier and multivariable (MVA) logistic regression and Cox proportional hazard regression analyses were performed to identify patient, tumor, and treatment characteristics predictive of locoregional control (LRC) and overall survival (OS). RESULTS: A total of 180 patients met entry criteria, with a median follow-up time of 4.9 years (range, 0.9-12.5 years); 102 patients (56.7%) were female and 42 patients (23.3%) were younger than 45 years at diagnosis. One hundred fifty-three patients (85%) had T1/T2 tumors, and 112 patients (62%) had elective neck dissections with confirmed pN0. Lymphovascular space invasion (LVSI) was present in 36 patients (20%). On MVA, LVSI (OR, 0.06; 95% CI, 0.02-0.19; P < .01) was associated with worse LRC. Elective neck dissection (odds ratio [OR], 2.99; 95% CI, 1.16-7.73; P = .02) and receipt of RT (OR, 7.74; 95% CI, 2.27-26.42; P < .01) were associated with improved LRC. Three-year LRC rates were significantly lower for patients with LVSI (38.8%; 95% CI, 22.8%, 54.6%) than those without LVSI (81.9%; 95% CI, 74.4%, 87.4%). On MVA, only LVSI (hazard ratio, 2.20; 95% CI, 1.19-4.06; P = .01) and age greater than 44 years (hazard ratio, 4.38; 95% CI, 1.34-14.27; P = .01) were associated with worse OS. Three-year OS rates were significantly lower in patients with LVSI (71.3%; 95% CI, 53.2%-83.4%) than those without LVSI (90.3%; 95% CI, 83.8%-94.3%). CONCLUSIONS AND RELEVANCE: Lymphovascular space invasion in patients with node-negative oral tongue cancer treated with upfront definitive surgery is associated with worse LRC and OS. Node-negative oral cavity cancers with LVSI warrant consideration of further adjuvant therapy, which should be further evaluated in a prospective setting.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Cassidy RJ, Switchenko JM, Jegadeesh N, et al. Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28097311. doi:10.1001/jamaoto.2016.3795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。